Mối Quan Hệ Giữa Việc Tiêu Thụ Rượu Nhẹ Đến Trung Bình với Chuyển Hóa Glucose và Kháng Insulin ở Người Trưởng Thành Không Bị Đái Tháo Đường: Những Ảnh Hưởng Điều Tiết của Mức Độ Triệu Chứng Trầm Cảm, Mỡ Thể và Giới Tính

Edward C. Suarez1, Jean C. Beckham2,3,4, Kimberly T. Green1
1Duke University Medical Center Durham, USA
2Duke University Medical Center, Durham, USA
3Department of Veterans Affairs Medical Center, Durham, USA
4VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center, Durham, USA

Tóm tắt

Chúng tôi đã khảo sát mối quan hệ giữa việc tiêu thụ rượu với chuyển hóa glucose và kháng insulin (IR) như một chức năng của triệu chứng trầm cảm, tình trạng béo phì và giới tính. Những người trưởng thành khỏe mạnh (từ 18–65 tuổi) đã cung cấp mẫu máu lúc đói và thông tin về các yếu tố lối sống. Việc tiêu thụ rượu được phân loại thành không bao giờ, hiếm (1–3 ly/tháng), thỉnh thoảng (1–7 ly/tuần) và thường xuyên (≥2 ly/ngày). Bảng Đánh Giá Trầm Cảm Beck (BDI) được sử dụng để đánh giá mức độ triệu chứng. Các kết quả chính bao gồm insulin lúc đói, glucose và IR được đánh giá thông qua mô hình đánh giá trạng thái đồng sinh (HOMA). Trong phân tích đơn biến, việc tiêu thụ rượu có mối liên hệ tiêu cực với HOMA-IR (p = 0.03), insulin (p = 0.007) và chỉ số khối cơ thể (BMI) (p = 0.04), nhưng không liên quan đến glucose hoặc BDI. Sau khi điều chỉnh cho các yếu tố có thể gây nhiễu bao gồm BMI, việc tiêu thụ rượu có liên quan đến HOMA-IR (p = 0.01) và insulin (p = 0.009) tùy thuộc vào BDI và giới tính. Đối với phụ nữ có triệu chứng trầm cảm tối thiểu, việc tiêu thụ rượu nhẹ đến vừa đã liên quan đến HOMA-IR và insulin thấp hơn. Việc tiêu thụ rượu không liên quan đến các chỉ số chuyển hóa ở phụ nữ có triệu chứng trầm cảm cao hơn và ở nam giới. Trong phân tích sử dụng BMI như một yếu tố điều tiết liên tục, việc tiêu thụ rượu chỉ liên quan đến insulin (p = 0.004). So sánh hậu kiểm giữa các nhóm BMI (<25 so với ≥25 kg/m2) cho thấy rằng việc tiêu thụ rượu nhẹ đến vừa có liên quan đến insulin thấp hơn nhưng chỉ ở những đối tượng có BMI ≥ 25 kg/m2. Lợi ích của việc tiêu thụ rượu nhẹ đến vừa đối với insulin lúc đói và IR là khác biệt về giới và có vẻ được điều tiết độc lập bởi tình trạng béo phì và mức độ triệu chứng trầm cảm.

Từ khóa

#tiêu thụ rượu #chuyển hóa glucose #kháng insulin #triệu chứng trầm cảm #béo phì #giới tính

Tài liệu tham khảo

Baliunas DO, Taylor BJ, Irving H, et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123–32. doi:10.2337/dc09-0227. Athyros VG, Liberopoulos EN, Mikhailidis DP, et al. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology. 2008;58(6):689–97. doi:10.1177/0003319707306146. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342. doi:10.1136/bmj.d671. Carlsson S, Hammar N, Grill V. Alcohol consumption and type 2 diabetes meta-analysis of epidemiological studies indicates a U-shaped relationship. Diabetologia. 2005;48(6):1051–4. doi:10.1007/s00125-005-1768-5. Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care. 2015;38(9):1804–12. doi:10.2337/dc15-0710. Klatsky AL. Alcohol, cardiovascular diseases and diabetes mellitus. Pharmacol Res. 2007;55(3):237–47. doi:10.1016/j.phrs.2007.01.011. Koppes LLJ, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28(3):719–25. doi:10.2337/diacare.28.3.719. Bonnet F, Disse E, Laville M, et al. Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia. 2012;55(12):3228–37. doi:10.1007/s00125-012-2701-3. Taylor B, Irving HM, Baliunas D, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104(12):1981–90. doi:10.1111/j.1360-0443.2009.02694.x. Schrieks IC, Heil ALJ, Hendriks HFJ, Mukamal KJ, Beulens JWJ. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes Care. 2015;38(4):723–32. doi:10.2337/dc14-1556. Metcalf PA, Scragg RK, Jackson R. Light to moderate alcohol consumption is protective for type 2 diabetes mellitus in normal weight and overweight individuals but not the obese. J Obes. 2014;2014:634587. doi:10.1155/2014/634587. Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB Jr, Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care. 2000;23(11):1630–6. Vidot DC, Stoutenberg M, Gellman M, et al. Alcohol consumption and metabolic syndrome among Hispanics/Latinos: the Hispanic community health study/study of Latinos. Metab Syndr Relat Disord. 2016;14(7):354–62. doi:10.1089/met.2015.0171. Yokoyama H. Beneficial effects of ethanol consumption on insulin resistance are only applicable to subjects without obesity or insulin resistance; drinking is not necessarily a remedy for metabolic syndrome. Int J Environ Res Public Health. 2011;8(7):3019–31. doi:10.3390/ijerph8073019. Kroenke CH, Chu N-F, Rifai N, et al. A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic controla among 459 women. Diabetes Care. 2003;26(7):1971–8. doi:10.2337/diacare.26.7.1971. Suarez EC, Schramm-Sapyta NL, Vann Hawkins T, Erkanli A. Depression inhibits the anti-inflammatory effects of leisure time physical activity and light to moderate alcohol consumption. Brain Behav Immun. 2013;32:144–52. doi:10.1016/j.bbi.2013.03.009. Suarez E, Saab P, Llabre M, Kuhn C, Zimmerman E. Ethnicity, gender, and age effects on adrenoceptors and physiological responses to emotional stress. Psychophysiology. 2004;41(3):450–60. Yeung EH, Zhang C, Mumford SL, et al. Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study. J Clin Endocrinol Metab. 2010;95(12):5435–42. doi:10.1210/jc.2010-0702. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003;107:443–7. Movva R, Figueredo VM. Alcohol and the heart: to abstain or not to abstain? Int J Cardiol. 2013;164(3):267–76. doi:http://dx.doi.org/10.1016/j.ijcard.2012.01.030 Pai JK, Hankinson SE, Thadhani R, Rifai N, Pischon T, Rimm EB. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis. 2006;186(1):113–20. doi:10.1016/j.atherosclerosis.2005.06.037. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95. Aiken LS, West SG. Multiple regression: testing and interpreting interactions. Thousand Oaks: Sage; 1991. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287(19):2559–62. doi:10.1001/jama.287.19.2559. Flanagan DE, Moore VM, Godsland IF, Cockington RA, Robinson JS, Phillips DI. Alcohol consumption and insulin resistance in young adults. Eur J Clin Investig. 2000;30(4):297–301. Lazarus R, Sparrow D, Weiss ST. Alcohol intake and insulin levels: the Normative Aging Study. Am J Epidemiology. 1997;145(10):909–16. Johnston E, Johnson S, McLeod P, Johnston M. The relation of body mass index to depressive symptoms. Can J Public Health. 2004;95(3):179–83. Noh J-W, Kwon YD, Park J, Kim J. Body mass index and depressive symptoms in middle aged and older adults. BMC Public Health. 2015;15(1):310. doi:10.1186/s12889-015-1663-z. Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Campbell LV. Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity. Is abdominal adiposity the mediator? 2003;26(10):2734–2740. doi:10.2337/diacare.26.10.2734. Kozela M, Bobak M, Besala A, et al. The association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: prospective results of the HAPIEE study. Eur J Prevent Cardiol. 2016. doi:10.1177/2047487316649493. Carnethon MR, Biggs ML, Barzilay JI, et al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med. 2007;167:802–7. Khambaty T, Stewart JC, Muldoon MF, Kamarck TW. Depressive symptom clusters as predictors of 6-year increases in insulin resistance: data from the Pittsburgh healthy heart project. Psychosom Med. 2014;76(5):363–9. doi:10.1097/psy.0000000000000063. Joosten MM, Grobbee DE, van der A DL, Verschuren WM, Hendriks HF, Beulens JW. Combined effect of alcohol consumption and lifestyle behaviors on risk of type 2 diabetes. Am J Clin Nutr. 2010;91(6):1777–83. doi:10.3945/ajcn.2010.29170. Wakabayashi I, Groschner K. Modification of the association between alcohol drinking and non-HDL cholesterol by gender. Clin Chim Acta. 2009;404(2):154–9. doi:10.1016/j.cca.2009.03.047. Cooper DC, Trivedi RB, Nelson KM, et al. Sex differences in associations of depressive symptoms with cardiovascular risk factors and metabolic syndrome among African Americans. Cardiovascular Psychiatry and Neurology. 2013;2013:10. doi:10.1155/2013/979185. Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr. 2009;4(1):44–9. doi:10.1111/j.1559-4572.2008.00030.x. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52(2):239–43. doi:10.2337/diabetes.52.2.239. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Investig. 2006;116(7):1784–92. doi:10.1172/JCI29126. Ohman-Hanson RA, Cree-Green M, Kelsey MM, et al. Ethnic and sex differences in adiponectin: from childhood to adulthood. J Clin Endocrinol Metab. 2016;101(12):4808–15. doi:10.1210/jc.2016-1137. Bottner A, Kratzsch J, Muller G, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab. 2004;89(8):4053–61. doi:10.1210/jc.2004-0303. Carvalho AF, Rocha DQC, McIntyre RS, et al. Adipokines as emerging depression biomarkers: a systematic review and meta-analysis. J Psychiatr Res. 2014;59:28–37. doi:10.1016/j.jpsychires.2014.08.002. Wang Q, Zhu XC, Liu H, Ran MS, Fang DZ. A longitudinal study of the association of adiponectin gene rs1501299 with depression in Chinese Han adolescents after Wenchuan earthquake. J Affect Disord. 2015;175:86–91. doi:10.1016/j.jad.2014.12.056. Fredriksson J, Carlsson E, Orho-Melander M, Groop L, Ridderstråle M. A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects. Int J Obes. 2006;30(2):226–32. doi:10.1038/sj.ijo.0803138. Thamer C, Haap M, Fritsche A, Haering H, Stumvoll M. Relationship between moderate alcohol consumption and adiponectin and insulin sensitivity in a large heterogeneous population. Diabetes Care. 2004;27(5):1240. doi:10.2337/diacare.27.5.1240. Bell S, Britton A. The role of alcohol consumption in regulating circulating levels of adiponectin: a prospective cohort study. The Journal of Clinical Endocrinology & Metabolism. 2015;100(7):2763–8. doi:10.1210/jc.2015-1845. Makita S, Abiko A, Nagai M, et al. Influence of daily alcohol consumption on serum adiponectin levels in men. Metabolism—Clinical and Experimental. 62(3):411–6. doi:10.1016/j.metabol.2012.09.003. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism. 2004;53(4):495–9. doi:10.1016/j.metabol.2003.10.032. Wells JCK, Fewtrell MS. Measuring body composition. Arch Dis Child. 2006;91(7):612–7. doi:10.1136/adc.2005.085522. Graham K, Massak A, Demers A, Rehm J. Does the association between alcohol consumption and depression depend on how they are measured? Alcohol Clin Exp Res. 2007;31(1):78–88. doi:10.1111/j.1530-0277.2006.00274.x. Hunt M, Auriemma J, Cashaw ACA. Self-report bias and underreporting of depression on the BDI-II. J Pers Assess. 2003;80(1):26–30. doi:10.1207/S15327752JPA8001_10. Mayer EJ, Newman B, Quesenberry CP Jr, Friedman GD, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation. 1993;88(5 Pt 1):2190–7. Holbrook TL, Barrett-Connor E, Wingard DL. A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol. 1990;132(5):902–9. doi:10.1093/oxfordjournals.aje.a115733. Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate alcohol drinking and risk of diabetes in women. Am J Epidemiol. 1988;128(3):549–58. doi:10.1093/oxfordjournals.aje.a115002. Schmitz N, Deschenes SS, Burns RJ, et al. Depression and risk of type 2 diabetes: the potential role of metabolic factors. Mol Psychiatry. 2016. doi:10.1038/mp.2016.7. DiMatteo M, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7. doi:10.1001/archinte.160.14.2101. Suarez EC. Sex differences in the relation of depressive symptoms, hostility, and anger expression to indices of glucose metabolism in nondiabetic adults. Health Psychol. 2006;25(4):484–92.